4 Marijuana Stocks To Watch In The Fourth Quarter Of 2018

CORAL GABLES, FL / ACCESSWIRE / November 20,2018 / Marijuana stocks continue to grab more attention as the broader stock market has seen a strong sell-off this week. According toArcview Market Research and its research partner BDS Analytics, over the next 10 years, the legal cannabis industry is poised for explosive growth. Total expenditure on legal marijuana worldwide is expected to hit $57 billion by 2027.

Furthermore according to reports from firms like Deloitte*, "The total cannabis market in Canada, including medical and illegal as well as legal recreational products, is expected to generate up to $7.17 billion in total sales in 2019. Legal sales are expected to contribute more than half of this total-up to $4.34 billion-in the first year. Current and likely consumers expect to pay slightly more for legal products, with the former saying they're willing to pay 10 percent more."

While this market continues to take shape, here are four marijuana stocks to watch in the fourth quarter.

Leafbuyer Technologies ( LBUY ) announced this week that its quarterly sales rose 67% in the quarter ending September 30, 2018. The increase reflects the revenue booked in the quarter versus the same quarter of the previous year.

"Our record growth this quarter is a function of our bolstered national expansion and the higher dollar value we are receiving for our bundled packages," said Mark Breen, COO of Leafbuyer. "We are seeing a high demand for our loyalty services as well as our customer acquisition platform. We expect to see a significant increase in revenue coming from loyalty and order ahead products from our cannabis dispensary customers."

Similar to some of the larger cannabis companies, Leafbuyer has also been focusing on the acquisition trend within the industry. Earlier this month, Leafbuyer acquired Greenlight Technologies, a California-based application development company. Additionally, Leafbuyer inked a deal to provide a suite of services to Surterra Wellness. With eight locations in Florida, Surterra Wellness is one of the leading dispensary chains in the Sunshine State

For More Information On Leafbuyer Technologies, Click Here

Aphria Inc. (APHA) (APHA) recently announced its proposed acquisition of CC Pharma GmbH, a leading distributor of pharmaceutical products to more than 13,000 pharmacies in Germany.

The transaction, when closed, will strengthen the Company's end-to-end medical cannabis operations and infrastructure in Germany, a key market inAphria's international expansion. It is anticipated that the transaction will close in January 2019.

"This acquisition strengthens our foothold in Germany, one of the most highly sought-after medical cannabis markets in the world," said Vic Neufeld, CEO of Aphria. "CC Pharma is cash-flow positive and has significant experience with regulatory requirements and international logistics. It will be a strong addition toAphria's presence in Germany, providing deeper access to the important pharmacist channel and advancing our ambitious global growth strategy."

For More Information On Aphria, Click Here

MedMen Enterprises Inc. (OTCQX:MMNFF) (MMEN.CN) has been caught in the crossfire recently as share prices have tumbled. The company confirmed Monday that it had reduced a round of funding by nearly half, while its chief financial officer also submitted a resignation.

MedMen Chief Executive Adam Bierman said the change in the financing was related to a "global market selloff" and declined to comment on the CFO's departure.

"Shortly after the announcement, the global market experienced a significant selloff, and as we ended last week the investors that bought that deal would have been underwater," Bierman said. The company appointed the company's vice president of accounting, Jim Miller, as interim CFO.

On Tuesday, shares of MedMen saw lows of $3.30.

For More Information On MedMen, Click Here

Advantis Corp. (OTC PINK: ADVT) got off to a running start on Tuesday. Shares of the company hit highs of $0.051 during the morning session. CEO, Darren Cherry, stated last week that he foresees 20% quarter over quarter revenue growth for the foreseeable future. Today, he announced that a new development will result in a much larger revenue jump in the current quarter.